PACIOTTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.505
EU - Europa 1.228
AS - Asia 989
SA - Sud America 179
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.923
Nazione #
US - Stati Uniti d'America 1.471
SG - Singapore 429
IT - Italia 299
IE - Irlanda 244
CN - Cina 180
HK - Hong Kong 169
BR - Brasile 148
VN - Vietnam 123
FR - Francia 117
RU - Federazione Russa 116
DE - Germania 87
UA - Ucraina 76
FI - Finlandia 52
SE - Svezia 51
RO - Romania 49
GB - Regno Unito 37
CA - Canada 17
KR - Corea 17
BE - Belgio 16
TR - Turchia 16
PL - Polonia 15
NL - Olanda 13
IN - India 12
MX - Messico 12
AR - Argentina 11
JP - Giappone 11
AT - Austria 10
CZ - Repubblica Ceca 9
ES - Italia 9
CH - Svizzera 8
ZA - Sudafrica 8
GR - Grecia 7
EC - Ecuador 6
BD - Bangladesh 5
ID - Indonesia 4
IQ - Iraq 4
UZ - Uzbekistan 4
CL - Cile 3
CY - Cipro 3
JM - Giamaica 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
BO - Bolivia 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
KE - Kenya 2
KW - Kuwait 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
CR - Costa Rica 1
DZ - Algeria 1
EU - Europa 1
GY - Guiana 1
HN - Honduras 1
JO - Giordania 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.923
Città #
Singapore 291
Chandler 268
Dublin 244
Perugia 173
Hong Kong 165
San Mateo 104
Ashburn 80
Beijing 79
Ann Arbor 68
Dong Ket 67
Altamura 59
Boardman 59
Santa Clara 54
Bucharest 49
Wilmington 46
Medford 44
Princeton 44
Jacksonville 38
Lawrence 38
Moscow 35
Los Angeles 33
Munich 29
Ho Chi Minh City 27
Andover 26
Des Moines 24
New York 22
Redmond 21
Seoul 17
São Paulo 17
Helsinki 16
Brussels 15
The Dalles 15
Hanoi 14
Saint Petersburg 13
Nuremberg 12
Dallas 11
Denver 11
Houston 11
Turku 11
Warsaw 11
Brooklyn 10
Chennai 10
Redwood City 10
Seattle 10
London 9
Tokyo 9
Frankfurt am Main 8
Mexico City 8
Norwalk 8
Amsterdam 7
Chicago 7
Izmir 7
Montreal 7
San Paolo di Civitate 7
Stockholm 7
Johannesburg 6
Olomouc 6
Phoenix 6
Piscataway 6
Woodbridge 6
Fairfield 5
Falls Church 5
Milan 5
Belo Horizonte 4
Florence 4
Guangzhou 4
Lappeenranta 4
Manchester 4
Orem 4
Rome 4
Vancouver 4
Vienna 4
Ankara 3
Atlanta 3
Cambridge 3
Curitiba 3
Den Haag 3
Falkenstein 3
Guayaquil 3
Joinville 3
Nicosia 3
San Francisco 3
Shanghai 3
St Louis 3
Tashkent 3
Zhengzhou 3
Adrogué 2
Andradas 2
Assisi 2
Asunción 2
Baghdad 2
Bauru 2
Biên Hòa 2
Boston 2
Brasília 2
Brno 2
Buenos Aires 2
Changsha 2
Chattanooga 2
City of London 2
Totale 2.636
Nome #
CSF and blood biomarkers for Parkinson's disease 169
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 150
Accumulation of free oligosaccharides and tissue damage in cytosolic alpha-mannosidase (Man2c1)-deficient mice. 129
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 117
Lysosomal alpha-mannosidase and alpha-mannosidosis 109
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 107
Generation of a chitobiase knock out mouse model 105
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 105
di-N-acetylchitobiase-deficient mice accumulate Man2GlcNAc2 and Man3GlcNAc2 104
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 104
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 103
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 102
First pilot newborn screening for our lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene 99
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 98
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 96
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 95
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 92
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 90
Free oligosaccharides accumulation and tissue damages in Ma2c1 deficient mice 89
Identification of two novel beta-mannosidosis-associated sequence variants: biochemical analysis of beta mannosidase (MANBA) missense mutations. 88
Lysosomal di-N-acetylchitobiase-deficient mouse tissues accumulate Man2GlcNAc2 and Man3GlcNAc2 88
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 88
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 84
Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs) 83
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 83
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 83
Lysosomal enzymes in Parkinson's disease 82
Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma 80
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 79
Biochemical analysis of missense mutations in beta-mannosidosis 76
Origin of α-mannosidase activity in CSF 74
Lysosomal enzymes in PD: further evidence is needed. 69
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 69
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links 68
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 68
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes 68
Parkinson's and Lewy body dementia CSF biomarkers 67
Emerging therapies and therapeutic concepts for lysosomal storage diseases 64
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 63
Next generation sequencing applications in agro biotechnology 62
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 61
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 57
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 55
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 53
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease 53
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 51
Interlaboratory proficiency processing scheme in CSF aliquoting: Implementation and assessment based on biomarkers of Alzheimer's disease 50
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 49
Totale 4.078
Categoria #
all - tutte 18.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021195 0 0 0 0 0 9 23 11 33 16 21 82
2021/2022504 16 78 7 11 7 19 6 107 37 51 74 91
2022/2023841 51 160 15 74 62 92 0 32 312 1 31 11
2023/2024300 27 26 25 6 2 1 75 14 20 14 46 44
2024/2025753 4 56 29 41 78 50 41 38 160 57 135 64
2025/2026848 108 100 79 248 265 48 0 0 0 0 0 0
Totale 4.078